(BUD) Anheuser Busch Inbev - Overview
Exchange: NYSE •
Country: Belgium •
Currency: USD •
Type: Common Stock •
ISIN: US03524A1088
Stock:
Total Rating 55
Risk 77
Buy Signal 0.15
| Risk 5d forecast | |
|---|---|
| Volatility | 21.6% |
| Relative Tail Risk | -6.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 39.79 |
| Character TTM | |
|---|---|
| Beta | 0.231 |
| Beta Downside | 0.311 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.55% |
| CAGR/Max DD | 0.35 |
EPS (Earnings per Share)
Revenue
Description: BUD Anheuser Busch Inbev
Anheuser-Busch InBev SA/NV produces and sells beer in North America, Middle Americas, South America, Europe, the Middle East, Africa, and the Asia Pacific. It operates through North America, Middle Americas, South America, EMEA, Asia Pacific, and Global Export and Holding Companies segments. The company also offers flavored malt beverages, soft drinks, spirit-based ready-to-drink cocktails and beverages, and energy drinks. In addition, it operates BEES, a business-to-business digital commerce platform; on-demand delivery platforms under the Zé Delivery and TaDa Delivery brands; and premium at-home draft system under the PerfectDraft brand. The company provides a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona Extra, Michelob Ultra, and Stella Artois; Aguila, Brahma, Carling Black Label, Cass Fresh, Jupiler, Quilmes, SKOL, and Victoria; Beck's, Hoegaarden, and Leffe; Antarctica, Bud Light, Castle, Castle Lite, Cristal, Harbin, Modelo Especial, Sedrin, and Skol brands, as well as non-beer brands comprising Brutal Fruit, Cutwater, and NÜTRL brands. The company was formerly known as InBev SA and changed its name to Anheuser-Busch InBev SA/NV in November 2008. Anheuser-Busch InBev SA/NV was founded in 1366 and is headquartered in Leuven, Belgium.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 9.56b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.29 > 1.0 |
| NWC/Revenue: -10.86% < 20% (prev -13.46%; Δ 2.60% < -1%) |
| CFO/TA 0.07 > 3% & CFO 14.84b > Net Income 9.56b |
| Net Debt (61.39b) to EBITDA (27.47b): 2.23 < 3 |
| Current Ratio: 0.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.98b) vs 12m ago -1.26% < -2% |
| Gross Margin: 56.07% > 18% (prev 0.46%; Δ 5561 % > 0.5%) |
| Asset Turnover: 42.02% > 50% (prev 36.21%; Δ 5.81% > 0%) |
| Interest Coverage Ratio: 2.47 > 6 (EBITDA TTM 27.47b / Interest Expense TTM 7.81b) |
Altman Z'' 1.52
| A: -0.04 (Total Current Assets 24.77b - Total Current Liabilities 34.48b) / Total Assets 218.81b |
| B: 0.23 (Retained Earnings 50.13b / Total Assets 218.81b) |
| C: 0.09 (EBIT TTM 19.33b / Avg Total Assets 212.72b) |
| D: 0.43 (Book Value of Equity 51.86b / Total Liabilities 121.07b) |
| Altman-Z'' Score: 1.52 = BB |
Beneish M -3.02
| DSRI: 1.06 (Receivables 6.95b/5.50b, Revenue 89.38b/74.81b) |
| GMI: 0.83 (GM 56.07% / 46.43%) |
| AQI: 1.00 (AQ_t 0.78 / AQ_t-1 0.77) |
| SGI: 1.19 (Revenue 89.38b / 74.81b) |
| TATA: -0.02 (NI 9.56b - CFO 14.84b) / TA 218.81b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of BUD shares?
As of February 27, 2026, the stock is trading at USD 78.59 with a total of 3,264,652 shares traded.
Over the past week, the price has changed by -0.38%, over one month by +13.24%, over three months by +25.64% and over the past year by +46.27%.
Over the past week, the price has changed by -0.38%, over one month by +13.24%, over three months by +25.64% and over the past year by +46.27%.
Is BUD a buy, sell or hold?
Anheuser Busch Inbev has received a consensus analysts rating of 4.15.
Therefore, it is recommended to buy BUD.
- StrongBuy: 5
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BUD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.9 | 11.8% |
| Analysts Target Price | 87.9 | 11.8% |
BUD Fundamental Data Overview February 21, 2026
P/E Trailing = 23.236
P/E Forward = 19.3424
P/S = 2.5799
P/B = 1.9361
P/EG = 1.9603
Revenue TTM = 89.38b USD
EBIT TTM = 19.33b USD
EBITDA TTM = 27.47b USD
Long Term Debt = 70.35b USD (from longTermDebt, last quarter)
Short Term Debt = 899.0m USD (from shortTermDebt, last quarter)
Debt = 73.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.39b USD (from netDebt column, last quarter)
Enterprise Value = 214.12b USD (153.04b + Debt 73.03b - CCE 11.94b)
Interest Coverage Ratio = 2.47 (Ebit TTM 19.33b / Interest Expense TTM 7.81b)
EV/FCF = 19.12x (Enterprise Value 214.12b / FCF TTM 11.20b)
FCF Yield = 5.23% (FCF TTM 11.20b / Enterprise Value 214.12b)
FCF Margin = 12.53% (FCF TTM 11.20b / Revenue TTM 89.38b)
Net Margin = 10.70% (Net Income TTM 9.56b / Revenue TTM 89.38b)
Gross Margin = 56.07% ((Revenue TTM 89.38b - Cost of Revenue TTM 39.26b) / Revenue TTM)
Gross Margin QoQ = 55.88% (prev 56.41%)
Tobins Q-Ratio = 0.98 (Enterprise Value 214.12b / Total Assets 218.81b)
Interest Expense / Debt = 3.09% (Interest Expense 2.25b / Debt 73.03b)
Taxrate = 23.63% (1.38b / 5.83b)
NOPAT = 14.76b (EBIT 19.33b * (1 - 23.63%))
Current Ratio = 0.72 (Total Current Assets 24.77b / Total Current Liabilities 34.48b)
Debt / Equity = 0.84 (Debt 73.03b / totalStockholderEquity, last quarter 87.29b)
Debt / EBITDA = 2.23 (Net Debt 61.39b / EBITDA 27.47b)
Debt / FCF = 5.48 (Net Debt 61.39b / FCF TTM 11.20b)
Total Stockholder Equity = 87.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.49% (Net Income 9.56b / Total Assets 218.81b)
RoE = 10.99% (Net Income TTM 9.56b / Total Stockholder Equity 87.02b)
RoCE = 12.28% (EBIT 19.33b / Capital Employed (Equity 87.02b + L.T.Debt 70.35b))
RoIC = 9.40% (NOPAT 14.76b / Invested Capital 157.12b)
WACC = 5.34% (E(153.04b)/V(226.06b) * Re(6.77%) + D(73.03b)/V(226.06b) * Rd(3.09%) * (1-Tc(0.24)))
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF] Terminal Value 86.31% ; FCFF base≈11.19b ; Y1≈11.16b ; Y5≈11.75b
[DCF] Fair Price = 168.1 (EV 350.67b - Net Debt 61.39b = Equity 289.28b / Shares 1.72b; r=5.90% [WACC]; 5y FCF grow -0.88% → 2.90% )
EPS Correlation: 66.05 | EPS CAGR: 13.04% | SUE: 0.85 | # QB: 1
Revenue Correlation: 11.87 | Revenue CAGR: 25.05% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.94 | Chg7d=+0.945 | Chg30d=+0.945 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=4.36 | Chg7d=+0.187 | Chg30d=+0.194 | Revisions Net=+2 | Growth EPS=+16.9% | Growth Revenue=+7.0%
EPS next Year (2027-12-31): EPS=4.96 | Chg7d=+0.202 | Chg30d=+0.200 | Revisions Net=+2 | Growth EPS=+13.7% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.6% (Discount Rate 7.9% - Earnings Yield 4.3%)
[Growth] Growth Spread = +6.0% (Analyst 9.7% - Implied 3.6%)
P/E Forward = 19.3424
P/S = 2.5799
P/B = 1.9361
P/EG = 1.9603
Revenue TTM = 89.38b USD
EBIT TTM = 19.33b USD
EBITDA TTM = 27.47b USD
Long Term Debt = 70.35b USD (from longTermDebt, last quarter)
Short Term Debt = 899.0m USD (from shortTermDebt, last quarter)
Debt = 73.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.39b USD (from netDebt column, last quarter)
Enterprise Value = 214.12b USD (153.04b + Debt 73.03b - CCE 11.94b)
Interest Coverage Ratio = 2.47 (Ebit TTM 19.33b / Interest Expense TTM 7.81b)
EV/FCF = 19.12x (Enterprise Value 214.12b / FCF TTM 11.20b)
FCF Yield = 5.23% (FCF TTM 11.20b / Enterprise Value 214.12b)
FCF Margin = 12.53% (FCF TTM 11.20b / Revenue TTM 89.38b)
Net Margin = 10.70% (Net Income TTM 9.56b / Revenue TTM 89.38b)
Gross Margin = 56.07% ((Revenue TTM 89.38b - Cost of Revenue TTM 39.26b) / Revenue TTM)
Gross Margin QoQ = 55.88% (prev 56.41%)
Tobins Q-Ratio = 0.98 (Enterprise Value 214.12b / Total Assets 218.81b)
Interest Expense / Debt = 3.09% (Interest Expense 2.25b / Debt 73.03b)
Taxrate = 23.63% (1.38b / 5.83b)
NOPAT = 14.76b (EBIT 19.33b * (1 - 23.63%))
Current Ratio = 0.72 (Total Current Assets 24.77b / Total Current Liabilities 34.48b)
Debt / Equity = 0.84 (Debt 73.03b / totalStockholderEquity, last quarter 87.29b)
Debt / EBITDA = 2.23 (Net Debt 61.39b / EBITDA 27.47b)
Debt / FCF = 5.48 (Net Debt 61.39b / FCF TTM 11.20b)
Total Stockholder Equity = 87.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.49% (Net Income 9.56b / Total Assets 218.81b)
RoE = 10.99% (Net Income TTM 9.56b / Total Stockholder Equity 87.02b)
RoCE = 12.28% (EBIT 19.33b / Capital Employed (Equity 87.02b + L.T.Debt 70.35b))
RoIC = 9.40% (NOPAT 14.76b / Invested Capital 157.12b)
WACC = 5.34% (E(153.04b)/V(226.06b) * Re(6.77%) + D(73.03b)/V(226.06b) * Rd(3.09%) * (1-Tc(0.24)))
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF] Terminal Value 86.31% ; FCFF base≈11.19b ; Y1≈11.16b ; Y5≈11.75b
[DCF] Fair Price = 168.1 (EV 350.67b - Net Debt 61.39b = Equity 289.28b / Shares 1.72b; r=5.90% [WACC]; 5y FCF grow -0.88% → 2.90% )
EPS Correlation: 66.05 | EPS CAGR: 13.04% | SUE: 0.85 | # QB: 1
Revenue Correlation: 11.87 | Revenue CAGR: 25.05% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.94 | Chg7d=+0.945 | Chg30d=+0.945 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=4.36 | Chg7d=+0.187 | Chg30d=+0.194 | Revisions Net=+2 | Growth EPS=+16.9% | Growth Revenue=+7.0%
EPS next Year (2027-12-31): EPS=4.96 | Chg7d=+0.202 | Chg30d=+0.200 | Revisions Net=+2 | Growth EPS=+13.7% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.6% (Discount Rate 7.9% - Earnings Yield 4.3%)
[Growth] Growth Spread = +6.0% (Analyst 9.7% - Implied 3.6%)